Navigation Links
Mayo Clinic researchers find that protein believed to protect against cancer has a Mr. Hyde side
Date:9/3/2009

JACKSONVILLE, Fla. In a biological rendition of fiction's Strange Case of Dr. Jekyll and Mr. Hyde, researchers from the Mayo Clinic campus in Florida and Harvard Medical School have found that a protein thought to protect against cancer development can actually spur the spread of tumors.

The scientists, reporting in the Sept. 3 issue of Molecular and Cellular Biology, found that FOXO3a, a transcription factor that regulates gene expression, becomes active when growing cancer cells begin to starve. Their research suggests that this protein then turns on molecular switches that allow the cancer cells to invade surrounding tissues.

"This is a complete reversal of what everyone thought about FOXO3a that we should find a way to activate this transcription factor so as to fight cancer growth," says cancer biologist Peter Storz, Ph.D., the study's lead investigator from Mayo Clinic in Florida.

Findings from the study, which was funded in part by the Florida Department of Health, illustrate the growing recognition in the research community that proteins can play multiple roles with respect to tumor progression, he says.

"More and more we see that, when it comes to cancer, proteins can have split personalities," Dr. Storz says. "Proteins once firmly believed to be tumor suppressors that protect against cancer development have recently been found to act as oncogenes, or cancer promoters, in certain cancers and in some biological circumstances. We now understand that proteins behave in different ways, depending on the cellular context."

Dr. Storz and his laboratory colleagues focus on understanding how cancer cells spread. This study builds upon a recent finding by collaborating author Alex Toker, Ph.D., associate professor, Department of Pathology, Harvard Medical School. Dr. Toker had found that Akt, a protein that protects tumor cells from programmed cell death and induces proliferation of cancer, in some circums
'/>"/>

Contact: Kevin Punsky
punsky.kevin@mayo.edu
904-953-2299
Mayo Clinic
Source:Eurekalert

2

GOOD

Page: 1 2

Related biology news :

1. General tumor marker test now offered by GenWay clinical laboratory
2. Neurimmune Therapeutics Announces Advancement of Alzheimers Program into Preclinical Development
3. Antibody targeting of glioblastoma shows promise in preclinical tests, say Lombardi researchers
4. $20 million NIH grant to transform clinical research at UIC
5. Systems biology recommended as a clinical approach to cancer
6. Funxional successfully completes initial clinical trial of FX125L, an anti-inflammatory drug with a novel mechanism of action
7. Clinical trial shows quadriplegics can operate powered wheelchair with tongue drive system
8. Versartis presents positive preclinical data on 2 product candidates at ENDO 09
9. Brain-computer interface, developed at Brown, begins new clinical trial
10. REGiMMUNE presents enhanced efficacy data in preclinical transplantation models
11. SNMs clinical trials network gains added support from industry leader
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... CSC (NYSE: CSC ... for Laboratory Accreditation awarded the International Organization ... to the company,s Test Lab, which is ... in Fairmont, W.Va. The Test Lab is ... world to achieve this accomplishment. ,, ...
(Date:12/15/2009)... just signed an agreement with the British Society for ... with the journal Biogerontology for an initial ... one member of the Biogerontology editorial board ... Springer will sponsor the society and provide society ... on www.springerlink.com . , Biogerontology offers ...
(Date:12/15/2009)... German ., Despite the fact that physical ... vary as to how space is encoded in their ... such as ,left, right, front, back, to talk about ... east, west, at all times for all scales: "The ... an snake by your Northern leg". Whether not only ...
Breaking Biology News(10 mins):CSC's Identity Management and Biometric Test Lab Achieves ISO/IEC 17025 Accreditation 2More than a jump to the left 2S Epatha Merkerson Lends Star Power to Support the American Lung Associations Christmas Seals Campaign as Celebrity Chairperson 59524 1S Epatha Merkerson Lends Star Power to Support the American Lung Associations Christmas Seals Campaign as Celebrity Chairperson 59524 2JGI Completes Successful Upgrade of ADP Enterprise V5 at Washington Hospital Healthcare System 59522 1JGI Completes Successful Upgrade of ADP Enterprise V5 at Washington Hospital Healthcare System 59522 2Cytochroma Appoints Dr John Cunningham to its Scientific Advisory Board 14483 1Cytochroma Appoints Dr John Cunningham to its Scientific Advisory Board 14483 2Cytochroma Appoints Dr John Cunningham to its Scientific Advisory Board 14483 3
... to think he was eccentric, crawling like Spiderman along ... dental tools and a jack hammer. , Now, ... it, and are congratulating him on receiving the 2007 ... at the Geological Society of Americas recent annual meeting ...
... Amsterdam, The Netherlands, January 14, 2008 A rapid ... genotypes has been developed by researchers from the Department ... Medical University, Guangzhou, China. This assay combines PCR and ... of the human population, which in turn will help ...
... arthritis may also play a role in human height, ... co-led by the University of Michigan School of Public ... online Jan. 13. , The new study confirms ... height and increased risk of osteoarthritis, the most common ...
Other Biology News:Academy volunteer wins national paleontology award 2New method developed to identify genetic determinants of Alzheimer's disease 2Study suggests genetic connection between short stature and arthritis 2
(Date:12/16/2009)... Dec. 16 WaferGen Biosystems, Inc. (OTC ... genetic analysis systems, today announced that it will ... innovative service for gene-expression profiling using its SmartChip(TM) ... provides the most comprehensive human microRNA panel of ... company,s SmartChip service offers customers the use of ...
(Date:12/16/2009)... -- Capitalizing on the continued strong growth ... venture capital market, leaders from BioCrossroads, Eli Lilly ... University, Purdue University, the University of Notre Dame, ... announced the establishment of the INext Fund, a ... Organized through BioCrossroads, Indiana,s initiative to grow, expand ...
(Date:12/16/2009)... to Special Protocol Assessment with the Food ... 16 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: ... a global biopharmaceutical company focused on oncology ... by its partner Keryx Biopharmaceuticals Inc. ("Keryx") ... clinical trial for perifosine (KRX-0401), the Company,s ...
(Date:12/16/2009)... American Filtration and Separations Society will hold its 23rd Annual Technical ... Hotel in San Antonio, Texas. To further impact the separation society ... are proud to announce that the 2010 AFS Annual Technical Conference ... , ... Minneapolis, MN (PRWEB) December 16, 2009 -- ...
Breaking Biology Technology:WaferGen to Launch Human MicroRNA Panel for Gene-Expression Profiling of 885 MicroRNA for Its Service Using the SmartChip(TM) Real-Time PCR System 2WaferGen to Launch Human MicroRNA Panel for Gene-Expression Profiling of 885 MicroRNA for Its Service Using the SmartChip(TM) Real-Time PCR System 3WaferGen to Launch Human MicroRNA Panel for Gene-Expression Profiling of 885 MicroRNA for Its Service Using the SmartChip(TM) Real-Time PCR System 4Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 2Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 3Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 4Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 5AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 2AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 3AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 4AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 5American Filtration and Separations Society to Hold 23nd Annual Technical Conference 2American Filtration and Separations Society to Hold 23nd Annual Technical Conference 3American Filtration and Separations Society to Hold 23nd Annual Technical Conference 4
... /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals,Inc. (NASDAQ: ANPI ... received a,favourable decision from the Intellectual Property ... Johnson & Johnson,s subsidiary, Conor Medsystems,Inc. ("Conor") ... which,pertains to compositions comprising a polymer and ...
... Corporation, a,leading contract services organization for the ... to offer their,GreenScreen HC in vitro assay ... of,genotoxicity screening services. GreenScreen HC, in conjunction ... test for genotoxic potential,earlier in the preclinical ...
... 2007 Medical Products Industry Leader, DEERFIELD, Ill., Sept. ... today that it has been named 2007,Medical Products Industry ... and the Dow Jones Sustainability North America Index,(DJSI North ... has been listed in the DJSI and the sixth ...
Other Biology Technology:Angiotech receives favourable patent decision from New Zealand's Intellectual Property Office 2Angiotech receives favourable patent decision from New Zealand's Intellectual Property Office 3Angiotech receives favourable patent decision from New Zealand's Intellectual Property Office 4BioReliance Launches Next-Generation Genotoxicity Screening Service 2Baxter Named to Dow Jones Sustainability Index for Ninth Consecutive Year 2
COMING SOON: Anti-Mouse CD205 (DEC-205),Clone NLDC-145, mAb...
Rabbit polyclonal to ErbB 2 ( Abpromise for all tested applications). entrezGeneID: 2064 SwissProtID: P04626...
Anti-CoralHue Dronpa Green Monoclonal Antibody Research Focus: cell surface antigens Storage: -20C Shipping Temperature: +4C...
Phospho-FKHR (Thr24)/FKHRL1 (Thr32) Antibody...
Biology Products: